Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions



Rating:

Share or cite this content

Citations should be made in the following way:
M. Locatelli (Lissone, Italy), A. Cima (Monza, Italy), F. D'Abrosca (Milano, Italy). EFA technology efficacy on oropharyngeal secretions management in subjects with DOC. 2002

Member's Comments

No comment yet.

Related content which might interest you: Feasibility and safety evaluation of Simeox airway clearance technique (ACT) in patients with bronchiectasis Source: International Congress 2019 – Highlights in lung function and chronic cough Year: 2019 The effectiveness of fluconazol application in patients with bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 543s Year: 2004 Quantitative assessment of hyposalivation and the risk of oropharyngeal problems in asthmatic patients Source: International Congress 2018 – Determinants and monitoring of asthma control Year: 2018 The oropharyngeal microbiome of COPD patients and controls in a livestock dense area Source: Virtual Congress 2021 – Environment and respiratory health Year: 2021 Comparative study of RSV detection by two collect methodologies: nasopharyngeal aspirate and oropharyngeal rubbing Source: Eur Respir J 2005; 26: Suppl. 49, 27s Year: 2005 Initial acceptance and compliance to nasal CPAP in elderly patients Source: Annual Congress 2009 - Sleep apnoea across the ages Year: 2009 The effectiveness and safety of pre-hospital nebulizer therapy of elderly patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 503s Year: 2002 Effect of nasal continuous positive airway pressure therapy on quality of life outcomes – a cost-utility analysis Source: Eur Respir J 2006; 28: Suppl. 50, 199s Year: 2006 Characterization of omalizumab partitioning in the nasal mucosa of patients Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 SNOT-22 items and association with objective measures in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from SINUS-24 and SINUS-52 trials Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials Year: 2021 Sources of origin of the oropharyngeal microbiota in patients with different phenotypes of COPD Source: International Congress 2017 – COPD management: new findings from large studies Year: 2017 Feasibility and safety of a dosimetric bronchial challenge test for infants Source: Eur Respir J 2005; 26: Suppl. 49, 675s Year: 2005 The comparative assessment of quality of life in asthma patients treated with inhaled steroids Source: Eur Respir J 2003; 22: Suppl. 45, 282s Year: 2003 The impact of smoking on airway microbiome and mycobiome of COPD/AECOPD patients Source: International Congress 2018 – Studies on the mechanisms underlying airway disease Year: 2018 Study of external breathing function intercommunication with content of urinary acid in the blood of patients ill with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 400s Year: 2003 Acceptability and effectiveness of a new device in the management of airways clearance Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Contamination of bronchoscopic sample by oropharyngeal flora Source: Annual Congress 2009 - Trends in bronchoscopy Year: 2009 Comparision of patient acceptability and clinical efficacy of different inhaler devices in asthmatics Source: Annual Congress 2007 - Recent advances in our understanding of the treatment of asthma Year: 2007 Effects of topical therapy on the breath pattern of patients with newly diagnosed COPD: An e-nose based study Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Measurement of snoring and stertor using the Sonomat to assess effectiveness of upper airway surgery in children Source: Sleep and Breathing Conference 2021 Year: 2021